HCW Biologics Inc. (HCWB) vs Purple Biotech Ltd. Sponsored ADR (PPBT)

HCW Biologics Inc. and Purple Biotech Ltd. Sponsored ADR are both Biotechnology companies. HCW Biologics Inc. is the larger, with a market value of $2.3M against $2.0M — 1.1× the size. Purple Biotech Ltd. Sponsored ADR has the higher net margin (0.00% vs −329.4%) and the lower return on invested capital (−290.3% vs −36.2%). Across the 14 metrics below, Purple Biotech Ltd. Sponsored ADR leads on 8 and HCW Biologics Inc. on 6.

Valuation

Metric HCWB PPBT Biotechnology median
P/E n/m n/m 10.60
P/S 0.20 n/m 9.40
P/B 0.18 0.11 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.15 0.66
EV/Sales 1.12 n/m 9.02
Earnings yield (2,786.94%) (3,843.12%) (32.88%)
Free cash flow yield (915.31%) (573.06%) (23.13%)

Profitability

Metric HCWB PPBT Biotechnology median
Gross margin 95.91% 0.00% 68.51%
Operating margin (114.02%) 0.00% 0.00%
Net margin (329.38%) 0.00% 0.00%
Free cash flow margin (180.57%) 0.00% 0.00%
Return on equity (600.32%) (110.67%) (51.96%)
Return on assets (79.52%) (100.91%) (46.06%)
Return on invested capital (36.15%) (290.25%) 0.00%

Growth

Metric HCWB PPBT Biotechnology median
Revenue growth (TTM) 706.96% — 6.76%
EPS growth (last fiscal year) 65.49% (10.14%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HCWB PPBT Biotechnology median
Debt to equity 0.88 0.00 0.00
Current ratio 0.06 3.70 4.97
Net debt to EBITDA (0.40) 0.35 1.01

Dividend

Metric HCWB PPBT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric HCWB PPBT Biotechnology median
Market cap 2.33m 2.03m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack